With obesity now recognized as a complex, chronic disease, the focus is rapidly shifting towards pharmacological innovations that go beyond traditional lifestyle and surgical interventions. Newer medicines such as GLP-1 receptor agonists are reshaping the therapeutic landscape with promising results in both weight reduction and metabolic risk management. 1 We invite you to join us on 7 th June 2025 , from 7:00 PM IST , for this focused scientific session featuring the distinguished speaker Dr. Arun Prasad with moderator Dr J Jayaprakashsai and chairperson Dr Tarun Sahni.
This session will distill actionable insights from current global evidence and clinical practice, covering newer weight management pharmacotherapies with integrative models for obesity care. We look forward to your participation in this transformative session. ##References## Rubino, D., Abrahamsson, N., Davies, M.,…
